556 related articles for article (PubMed ID: 26142912)
1. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912
[TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
[TBL] [Abstract][Full Text] [Related]
3. GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomized, multicenter study.
Muzii L; Boni T; Bellati F; Marana R; Ruggiero A; Zullo MA; Angioli R; Panici PB
Fertil Steril; 2010 Sep; 94(4):1496-1499. PubMed ID: 19541299
[TBL] [Abstract][Full Text] [Related]
4. Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study.
Leone Roberti Maggiore U; Scala C; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():157-62. PubMed ID: 25150954
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Treatment with Ulipristal Acetate before Outpatient Hysteroscopic Myomectomy.
Ferrero S; Scala C; Vellone VG; Paudice M; Vitale SG; Cianci A; Barra F
Gynecol Obstet Invest; 2020; 85(2):178-183. PubMed ID: 31940645
[TBL] [Abstract][Full Text] [Related]
6. Ulipristal Acetate Before High Complexity Hysteroscopic Myomectomy: A Retrospective Comparative Study.
Ferrero S; Racca A; Tafi E; Alessandri F; Venturini PL; Leone Roberti Maggiore U
J Minim Invasive Gynecol; 2016; 23(3):390-5. PubMed ID: 26707918
[TBL] [Abstract][Full Text] [Related]
7. Transrectal ultrasound-guided hysteroscopic myomectomy of submucosal myomas with a varying degree of myometrial penetration.
Ludwin A; Ludwin I; Pityński K; Basta P; Basta A; Banas T; Jach R; Wiecheć M; Grabowska R; Stangel-Wójcikiewicz K; Milewicz T; Nocuń A
J Minim Invasive Gynecol; 2013; 20(5):672-85. PubMed ID: 23850363
[TBL] [Abstract][Full Text] [Related]
8. A Multicenter Study Evaluating the Effect of Ulipristal Acetate during Myomectomy.
Murji A; Wais M; Lee S; Pham A; Tai M; Liu G
J Minim Invasive Gynecol; 2018; 25(3):514-521. PubMed ID: 29079463
[TBL] [Abstract][Full Text] [Related]
9. A new system to classify submucous myomas: a Brazilian multicenter study.
Lasmar RB; Lasmar BP; Celeste RK; da Rosa DB; Depes Dde B; Lopes RG
J Minim Invasive Gynecol; 2012; 19(5):575-80. PubMed ID: 22819007
[TBL] [Abstract][Full Text] [Related]
10. Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women.
Campo S; Campo V; Gambadauro P
Acta Obstet Gynecol Scand; 2005 Aug; 84(8):756-60. PubMed ID: 16026401
[TBL] [Abstract][Full Text] [Related]
11. [Operative hysteroscopy for myoma removal: Morcellation versus bipolar loop resection].
Hamidouche A; Vincienne M; Thubert T; Trichot C; Demoulin G; Nazac A; Fernandez H; Rivain AL; Deffieux X
J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):658-64. PubMed ID: 25287109
[TBL] [Abstract][Full Text] [Related]
12. Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study.
Ferrero S; Alessandri F; Vellone VG; Venturini PL; Leone Roberti Maggiore U
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():43-7. PubMed ID: 27566221
[TBL] [Abstract][Full Text] [Related]
13. Hysteroscopic management of large symptomatic submucous uterine myomas.
Camanni M; Bonino L; Delpiano EM; Ferrero B; Migliaretti G; Deltetto F
J Minim Invasive Gynecol; 2010; 17(1):59-65. PubMed ID: 20129334
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of a new two-step procedure for office hysteroscopic resection of submucous myomas: results of a pilot study.
Haimovich S; Mancebo G; Alameda F; Agramunt S; Solé-Sedeno JM; Hernández JL; Carreras R
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):191-4. PubMed ID: 23375904
[TBL] [Abstract][Full Text] [Related]
15. Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women.
Duhan N; Madaan S; Sen J
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):329-32. PubMed ID: 24103533
[TBL] [Abstract][Full Text] [Related]
16. Hysteroscopic morcellation versus bipolar resection for removal of type 0 and 1 submucous myomas: A randomized trial.
van Wessel S; van Vliet HAAM; Schoot BC; Weyers S; Hamerlynck TWO
Eur J Obstet Gynecol Reprod Biol; 2021 Apr; 259():32-37. PubMed ID: 33571839
[TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibitors for uterine fibroids.
Song H; Lu D; Navaratnam K; Shi G
Cochrane Database Syst Rev; 2013 Oct; (10):CD009505. PubMed ID: 24151065
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic Myomectomy for a Plethora of Submucous Myomas.
Paul PG; Paul G; Radhika KT; Bulusu S; Shintre H
J Minim Invasive Gynecol; 2017; 24(6):893-894. PubMed ID: 28232038
[TBL] [Abstract][Full Text] [Related]
19. Monopolar versus bipolar device: safety, feasibility, limits and perioperative complications in performing hysteroscopic myomectomy.
Litta P; Leggieri C; Conte L; Dalla Toffola A; Multinu F; Angioni S
Clin Exp Obstet Gynecol; 2014; 41(3):335-8. PubMed ID: 24992788
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative Effect of Preoperative Gonadotropin-Releasing Hormone Analogue Administration in Women Undergoing Cold Loop Hysteroscopic Myomectomy: A Randomized Controlled Trial.
Favilli A; Mazzon I; Grasso M; Horvath S; Bini V; Di Renzo GC; Gerli S
J Minim Invasive Gynecol; 2018; 25(4):706-714. PubMed ID: 29180306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
